Daniel D. Long insider trades

Open-market stock purchases and sales by Daniel D. Long, SVP, Drug Discovery at Septerna, Inc, from SEC Form 4 filings since Aug 7, 2025.

Recent trades

DateStockTradeValue
Sep 1, 2026SEPN Septerna, IncSold$126K
Sep 1, 2026SEPN Septerna, IncBought (not open market)$9.2K
Sep 1, 2026SEPN Septerna, IncBought (not open market)—
Aug 3, 2026SEPN Septerna, IncSold$34K
Aug 3, 2026SEPN Septerna, IncSold$80.9K
Aug 3, 2026SEPN Septerna, IncBought (not open market)$5K
Aug 3, 2026SEPN Septerna, IncBought (not open market)$4.2K
Aug 3, 2026SEPN Septerna, IncBought (not open market)—
Aug 3, 2026SEPN Septerna, IncBought (not open market)—
Jul 1, 2026SEPN Septerna, IncSold$71.6K
Jul 1, 2026SEPN Septerna, IncSold$42.9K
Jul 1, 2026SEPN Septerna, IncBought (not open market)$9.2K
Jul 1, 2026SEPN Septerna, IncBought (not open market)—
Jun 22, 2026SEPN Septerna, IncSold$281K
Jun 22, 2026SEPN Septerna, IncSold$252K
Jun 22, 2026SEPN Septerna, IncBought (not open market)—
Jun 22, 2026SEPN Septerna, IncBought (not open market)—
Feb 6, 2026SEPN Septerna, IncBought (not open market)—
Nov 10, 2025SEPN Septerna, IncSold$63.2K

Companies traded

  • SEPN Septerna, Inc: 8 sales, last Sep 1, 2026

Get free alerts when Daniel D. Long files a new trade →